Hims & Hers Stock: Ready To Outperform Further (NYSE:HIMS)

This article was written by Follow As an investor who started my path five years ago…

Hims & Hers Health: The Market Is Likely Wrong (NYSE:HIMS)

This article was written by Follow Stone Fox Capital (aka Mark Holder) is a CPA with…

Don’t Buy Hims & Hers Stock If You Want Better Than Mediocre Returns (NYSE:HIMS)

This article was written by Follow Oliver Rodzianko is an investment analyst specializing in the technology…

Hims & Hers Health’s chief commercial officer sells $50,594 in stock By Investing.com

Michael Chi, the Chief Commercial Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently sold shares…

Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It Lasted

Hims & Hers: FDA Ruling May Close Compounded GLP-1 Drug 'Loophole', It Was Fun While It…

Hims & Hers CEO Andrew Dudum sells shares worth $6.24 million By Investing.com

SAN FRANCISCO—Andrew Dudum, the Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently reported…